Stellar Health, a NYC-based healthcare technology company, raised over $60m in Series B funding.
The round was led by General Atlantic, with participation from Point72 Ventures and Primary Venture Partners, and new investors Mike Pykosz and Geoff Price, two of the co-founders of Oak Street Health.
The company intends to use the funds to grow its team, advance product development, engineering, and operations initiatives.
Founded in 2018 by Michael Meng, CEO, Stellar Health empowers providers to deliver value-based care through their cloud-native point-of-care platform. By integrating patient data, tracking provider workflows, and pushing meaningful, actionable insights directly to providers and practice staff, the platform helps primary care providers achieve value-based care outcomes for their patients. Using the platform, with its advanced system of analytics and identification, the primary care physician was informed of the patient’s heightened risk and had the right incentives to offer meaningful care at a critical time, placing the patient on secondary prevention treatments.
Since the beginning of 2020, the company has increased its payor and provider network, with more than 60 collaborations across 20 states, managing more than 375,000 patients in total.
